<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03482154</url>
  </required_header>
  <id_info>
    <org_study_id>16-1496.cc</org_study_id>
    <nct_id>NCT03482154</nct_id>
  </id_info>
  <brief_title>Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population</brief_title>
  <official_title>Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective chart review of patients who underwent a hematopoietic stem cell
      transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the
      relationship to specific outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective chart review of patients who underwent a hematopoietic stem cell
      transplant between 2007 and 2016 to evaluate incidence and risk factors of malglycemia. The
      review will also aim to characterize relationships between specific outcomes and malglycemia
      in pediatric HSCT patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Anticipated">July 26, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 26, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients experiencing malglycemia in primary admission for pediatric HSCT patients</measure>
    <time_frame>Transplant Day -14 to +100</time_frame>
    <description>hypoglycemia (BG &lt; 70 mg/dL), hyperglycemia (BG ≥ 126 mg/dL), or glycemic variability (σ ≥ 29 mg/dL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with versus without malglycemia who experience infection</measure>
    <time_frame>Transplant Day 0 to +100</time_frame>
    <description>It is hypothesized that patients who experience malglycemia will have an increased rate of post-transplant infections. This outcome will be assessed for differences in incidence based on malglycemia occurence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine whether specific exposures are associated with increased occurrence of malglycemia</measure>
    <time_frame>Transplant Day -14 to +100</time_frame>
    <description>The occurrence of the outcome, malglycemia, with be assessed for differences in incidence that may occur as a result of age, medication exposures (use of glucocorticoids, asparaginase, total parenteral nutrition (TPN), or calcineurin inhibitors), underlying diagnosis, and transplant type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate of patients with versus without malglycemia</measure>
    <time_frame>Transplant Day 0 through date of relapse or death</time_frame>
    <description>It is hypothesized that patients who experience malglycemia will have an increased rate of post-transplant mortality. This outcome will be assessed for differences in incidence based on malglycemia occurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of GVHD in patients with versus without malglycemia</measure>
    <time_frame>Transplant Day 0 through date of relapse or death</time_frame>
    <description>It is hypothesized that patients who experience malglycemia will have an increased rate of GVHD. This outcome will be assessed for differences in incidence based on malglycemia occurrence</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">344</enrollment>
  <condition>Stem Cell Transplant Complications</condition>
  <condition>Hyperglycemia</condition>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>With Malglycemia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Without Malglycemia</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hematopoietic Stem Cell Transplant</intervention_name>
    <description>Allogeneic and autologous stem cell transplants covering both malignant and non-malignant diagnoses.</description>
    <arm_group_label>With Malglycemia</arm_group_label>
    <arm_group_label>Without Malglycemia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who received hematopoietic stem cell transplants with the Bone Marrow
        Transplant Program at Children's Hospital Colorado from January 1, 2007 to July 31, 2016.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 0 to 30 years old at time of transplant

          -  Bone Marrow Transplant (BMT) recipient at Children's Hospital Colorado (CHCO) between
             1/1/2007 and 7/31/2016

        Exclusion Criteria:

          -  Preexisting diabetes mellitus or known hyperglycemia

          -  Inadequate blood glucose data for analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jenna Sopfe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Colorado</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

